These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3136893)

  • 1. [Pathogenic significance of endotoxemia in acute experimental liver failure].
    Fang YQ; Hou C
    Zhonghua Yi Xue Za Zhi; 1988 Mar; 68(3):147-9. PubMed ID: 3136893
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental studies on the changes of adrenergic receptors in rat liver with acute injury and in endotoxemia.
    Rao YP; Li SB
    J Tongji Med Univ; 1992; 12(2):116-9. PubMed ID: 1331487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of endotoxemia in galactosamine hepatitis by lactulose administered intravenously.
    Liehr H; Heine WD
    Hepatogastroenterology; 1981 Dec; 28(6):296-8. PubMed ID: 7345010
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endotoxins of Gram-negative bacteria in liver diseases].
    Bréchot C; Hecht Y; Ferrier JP
    Gastroenterol Clin Biol; 1980 Apr; 4(4):289-305. PubMed ID: 6765202
    [No Abstract]   [Full Text] [Related]  

  • 5. [The importance of intestinal endotoxins for the rise of toxic liver lesions from galactosamine].
    Grün M; Liehr H; Rasenack U
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():251-60. PubMed ID: 800910
    [No Abstract]   [Full Text] [Related]  

  • 6. Lactulose--a drug with antiendotoxin effect.
    Liehr H; Englisch G; Rasenack U
    Hepatogastroenterology; 1980 Oct; 27(5):356-60. PubMed ID: 7009359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of endotoxaemia in experimental "galactosamine-hepatitis" in the rat.
    Grün M; Liehr H; Rasenack U
    Acta Hepatogastroenterol (Stuttg); 1977 Apr; 24(2):64-81. PubMed ID: 857560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of preliminary fasting on the development of D-galactosamine-induced acute lesion of the liver in rats].
    Adzharov D; Donchev N; Kerimova M; Naĭdenova E; Borov B
    Biull Eksp Biol Med; 1989 Jan; 107(1):33-6. PubMed ID: 2914170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of partial hepatectomy on the hepatotoxicity of D-galactosamine.
    Andreicuţ S; Kerekes M
    Morphol Embryol (Bucur); 1982; 28(2):177-84. PubMed ID: 6213854
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental study of endotoxemia and reticuloendothelial system in hepatectomized cirrhotic rats].
    Nagashima I
    Nihon Geka Gakkai Zasshi; 1991 May; 92(5):551-61. PubMed ID: 1875896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced D-galactosamine hepatotoxicity after propylthiouracil treatment in the rat.
    Mihas TA; Ceballos R; Hirschowitz BI; Gibson RG; Mihas AA
    J Med; 1982; 13(1-2):71-9. PubMed ID: 6956652
    [No Abstract]   [Full Text] [Related]  

  • 12. [A research on the cholestasis caused by continuous endotoxemia].
    Nishida M; Tamakuma S; Idei T; Mochizuki H
    Nihon Geka Gakkai Zasshi; 1990 Feb; 91(2):184-90. PubMed ID: 2325602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats.
    Nagakawa J; Hirota K; Hishinuma I; Miyamoto K; Sonoda J; Yamanaka T; Katayama K; Yamatsu I
    J Pharmacol Exp Ther; 1993 Jan; 264(1):496-500. PubMed ID: 8423547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study on the role of endotoxin in the mechanism of galactosamine-induced liver injury].
    Tsubomizu Y; Kobayashi A; Sugata F
    Nihon Shokakibyo Gakkai Zasshi; 1986 Sep; 83(9):2035-42. PubMed ID: 3795572
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of DBcAMP on galactosamine-induced acute liver failure].
    Kakisaka A; Kasai S; Sawa M
    Nihon Geka Gakkai Zasshi; 1986 May; 87(5):581. PubMed ID: 3012316
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of silymarin on experimental liver lesions.
    Barbarino F; Neumann E; Deaciuc I; Ghelberg NW; Suciu A; Cotuţiu C; Racoviţă L; Stroilă C; Nagy S; Părău N; Toader S; Brilinschi C
    Med Interne; 1981; 19(4):347-57. PubMed ID: 7336095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The participation of the renin-angiotensin-aldosterone system in the pathogenesis of acute kidney failure in endotoxemia].
    Krishtal' NV; Frolov AF; Kukharchuk AL
    Lik Sprava; 1995; (3-4):92-4. PubMed ID: 8819932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective effect of hepatic stimulator substance against experimental acute liver failure in mice].
    An W; Mei MH
    Sheng Li Xue Bao; 1991 Oct; 43(5):415-27. PubMed ID: 1796305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactosamine- "hepatitis" in rats with different phagocytic activity of liver RES.
    Rasenack U; Grün M; Liehr H
    Acta Hepatogastroenterol (Stuttg); 1975 Feb; 22(1):29-35. PubMed ID: 1119301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective effect of a platelet activating factor antagonist in experimental liver injury].
    Zhang F
    Zhonghua Yi Xue Za Zhi; 1990 Jul; 70(7):375-8, 26. PubMed ID: 2171727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.